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Immunohistochemistry was used to examine the expression 
of p53 in pre-malignant oral lesions and oral squamous-cell 
carcinomas (SCCs) from Swedish and Sudanese snuff-dippers, 
as well as in pre-malignant oral lesions and oral SCCs from 
non-snuff-dippers from the Sudan, Sweden and Norway. Of the 
I4 SCCs from Sudanese snuff-dippers, 2 I % (3/ 14) expressed 
p53. Of the 14,60 and 4 I SCCs from non-snuff-dippers from the 
Sudan, Sweden and Norway, 64% (9/ 14). 65% (39/60) and 68% 
(28/4 I) expressed p53, respectively. A statistically significant 
difference in expression of p53 was found in SCCs from Suda- 
nese snuff-dippers compared to those from non-snuff-dippers 
from all/or any of the 3 countries. None of the suspected 
pre-malignant oral lesions from Sudanese snuff dippers or 
non-snuff-dippers expressed p53. Only 2 out of the I5 oral 
fibro-epithelial hyperplastic lesions from Swedish snuff-dippers 
expressed p53. Some of the oral epithelial dysplastic lesions, as 
well as the carcinoma in situ lesions from Norwegian non-snuff- 
dippers, expressed p53, while the oral fibro-epithelial hyperplas- 
tic lesions did not. The low relative frequency of p53 expression 
found in oral SCCs from snuff-dippers compared to those from 
non-snuff-dippers might suggest differences in mechanisms of 
oncogenic action induced by snuff. Alternatively, the pathogen- 
esis of malignant oral lesions from snuff-dippers may follow a 
p53-independent pathway. In view of the unusually high levels of 
the tobacco-specific nitrosamines (TSNA) found in the type of 
snuff used in the Sudan, investigations of p53 mutations or 
oncogenes are needed. 
Q 1996 Wiley-Lks, Inc. 
Squamous-cell carcinoma (SCC) of the head and neck ranks 
as the sixth most common malignant neoplasm world-wide 
(Parkin et al., 1993). In the developing countries, oral cavity 
and pharynx combined represent the third most common site 
of cancer (Johnson, 1991). The number of cases of this type of 
cancer is particularly high in Asia (Parkin et al., 1993) as well as 
in Africa (Idris et al., 199.5), and is now also increasing in the 
developed countries (Johnson, 1991). The etiology of oral 
SCCs has been associatcd with the use of  various forms of 
tobacco and/or alcohol consumption (Binnie et al., 1983; 
Johnson and Warnakulasuriya, 1993). In Norway, the use of 
snuff is relatively uncommon (Kraft and Svendsen, 1996) and 
oral-cancer incidence is also low (Hakulinen et al., 1986). The 
prevalence of oral cancer is particularly high in the ,Sudan 
(16.58%; Idris et al., 1995) compared to Sweden (2.1%; Ostman 
et al., 1995) and Norway (1.9% for males; 2.5% for females; 
Hakulinen et al., 1986). Descriptive and case-control studies 
from the Sudan (Elbeshir et al., 1989; Idris et al., 1994, 199.5) 
have documented an association between oral-cancer inci- 
dence and use of snuff (a mixture of tobacco and sodium 
bicarbonate). In Sweden, a possible link between oral-cancer 
incidence and snuff dipping has also been suggested (Hirsch 
and Johansson, 1983; Hirsch et al., 1984). 
The tumor-suppressor gene p53 encodes a nuclear phospho- 
protein that plays an important role in cell proliferation and 
differentiation (Harlow et al., 1985; Finlay et al., 1989). A 
deregulation of cell growth and differentiation occurs when 
this gene is deactivated by mutation or deletion, or by a virus 
(Harris, 1991). Several studies have reported the relationship 
between cigarette smoking, alcohol consumption (Field et al., 
1991; Brennan et al., 1995; Lazarus et al., 1996), betel and 
tobacco chewing (Kaur et al., 1994) and expression of p53 in 
oral SCCs. Howevcr, some studies have shown a lower preva- 
lence of p.53 expression in oral SCCs in tobacco chewers 
(Ranasinghc et al., 1993a, b; Thomas et al., 1994). 
The objective of thc present study was to determine the 
relative frequency of p.53 exprcssion in suspected oral pre- 
malignant lesions and in oral SCCs in relation to  use of snuff, 
as  a marker for p.53 mutation. 
MATERIAL AND METHODS 
During the period Novembcr 1993 to August 199.5, 39 
patients (29 males and 10 females, mean age 56.9 f 2.44 SE, 
SD 15.28, range 18-94 ycars) with suspected pre-malignant or 
malignant oral lesions presented at the Oral Surgery Depart- 
mcnt of the Khartoum Teaching Dental Hospital, Khartoum, 
Sudan. The patients were interviewed (Idris et al., 1994) on 
snuff use, ycars of usage. frequcncy of daily consumption, 
position of quid placement in the mouth and use of  other 
tobacco products. Of these patients, 17 males (59%) were 
found to dip snuff with a mean dipping period of 32 years 
(Table I),  while 5 females (50%) were found to dip snuff with a 
mean dipping period of  21 years (Table I). The remaining 
(n = 17) patients did not use snuff or any other form of 
tobacco. From each patient a surgical tissue sample was taken, 
fixed in 10% buffered formalin and dispatched to  the Dcpart- 
ment of Oral Pathology and Forensic Odontology, University 
of Bergen, where it was embedded in paraffin. 
From the period March 1992 to December 1993,15 patients 
(all males, mean age 39.5 2 1.03 SE, SD 12.5, range 23-74 
years) suspected of having snuff-induced oral lesions, pre- 
sented at the Department of Oral and Maxillofacial Surgery, 
Faculty of Odontology, Goteborg. The patients were inter- 
viewed on snuff use, years of usage, frequcncy of daily 
consumption, position of quid placement in the mouth and use 
of other tobacco products. All these patients were found to dip 
snuff with a mean dipping period of 1 1  years (Table I). After 
detailed history and clinical examination of the lesions, a 
surgical tissue sample was taken, fixed in 10% buffered 
formalin, and further embedded in paraffin. From the period 
March 1988 to December 1993, hospital records of 60 patients 
(27 males and 33 females, mean age 60.17 2 1.11  SE, SD 
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TABLE I -SITE DISTRIBUTION OF THE ORAL LESIONS 
(FIBRO-EPITHELIAL HYPERPLASIA. EPITHELIAL DYSPLASIA. 
CARCINOMA IN SITU A N D  SQUAMOUS-CELL CARCINOMAS) SELECTED 
FROM THE THREE COUNTRIES 
Site Sudan Sweden Norway 
Lip (upper or lower) (n = 82) 22 19 41 
Intraorall (n = 92) 17 56 19 
Total 39 75 60 
'Including gingiva, tongue, floor of mouth, buccal mucosa and 
palate. 
TABLE I1 - AGE A N D  SNUFF EXPOSURE DATA (MEAN f SD) AMONG 
SNUFF DIPPERS FROM THE SUDAN A N D  SWEDEN 
Age (years, Hours of daily Grams of snuff Years of 
snuff use used daily snufi use 
Sudan (n = 22) 
Males 60 f 2.11 18 f 6.1 42 2 11.2 32 f 6.3 
Females 52f 1.13 7 f  13.2 19 2 11.1 21 2 2.1 
Sweden (n = 15) 
Males 39.5 f 12.5 13.1 f 3.8 36.1 5 17.6 11 ? 2.3 
14.72, range 44-95 years) previously diagnosed with prc- 
malignant or malignant oral lesions at the Department of Oral 
and Maxillofacial Surgery, Faculty of Odontology, Goteborg, 
were randomly selected from the files of the Department of 
Oral Pathology, Faculty of Odontology, Goteborg. From the 
hospital records, only 8 patients (6 males and 2 females) 
reported cigarette smoking, with no further information on the 
amount smoked daily or weekly. Howevcr, no data on alcohol 
consumption were available. From the period January 1990 to 
November 1994, hospital records of 60 patients (30 males and 
30 females, mean age 64.04 f 1.72 SE, SD 14.42, range 31-88 
years), previously diagnosed with pre-malignant or malignant 
oral lesions, were randomly selected from the files of the 
Department of Pathology, Haukcland University Hospital, 
Bergen. There were 12 fibro-epithelial hyperplasias, 2 epithe- 
lial dysplasias, 5 carcinomas in situ and 41 oral SCCs. From the 
hospital records, only 11 patients (3796, all males) reported 
cigarette smoking, with no further information on the amount 
smoked daily or weekly. Similarly, no data on alcohol consump- 
tion were available. 
The site distributions of the biopsy specimens (n = 174) 
selected from the Sudan, Sweden and Norway are shown in 
Table 11. Data (except names and other identification num- 
bers) including age, sex, site of the lesion and previous 
histopathological diagnosis, were made available to the investi- 
gators. As positive controls, sections of formalin-fixed, paraffin- 
embedded tissue specimens from 5 carcinomas of the cervix 
that were previously p53-positive were included from the 
Department of Pathology, Haukcland University Hospital, 
Bergen. As negative controls, formalin-fixed, paraffin-embcd- 
ded tissue specimens of oral mucosa from 5 normal patients 
with no history of snuff dipping, cigarette smoking, use of any 
other form of tobacco and/or alcohol consumption were 
obtained from the same department. 
Tissue preparation 
From each biopsy specimen (n = 174), 5 sections ( 5  Fm) 
were prepared. One section was stained with hematoxylin and 
eosin (H. and E.) to evaluate the histopathological diagnosis. 
The remaining sections were used for immunohistochemistry. 
Evaluation of the H.  and E.-stained sections 
The H. and E.-stained sections were examined with a light 
microscope. The diagnoses werc then confirmed and the 
lesions wcre graded as fibro-epithelial hyperplasia, dysplasia 
(mild, moderak or severe). carcinoma in situ, or SCC. The 
SCCs were classified as  well, moderately or  poorly differcnti- 
ated according to Cawson and Eveson (1987). 
Irnrnunohistochernistry 
Monoclonal antibodies (MAbs). As described (Ibrahim et al., 
1996), 2 MAbs (DO-7 and DO-1) were used for detection of 
DO-7 (DAKO-p53, DAKO, Copenhagen, Denmark) rccog- 
nizes epitopes residing between amino acids (35-45) of human 
wild-type and mutant p53 (Vojtesek et al., 1992). It was diluted 
at 1:lOO in PBS, p H  7.2, containing 5% BSA. DO-1 (Santa 
Cruz Biotechnology, Santa Cruz, CA) reacts with an amino- 
acid terminal epitope (residues 3 7 4 5 )  of human wild-type and 
mutant p53 (Vojtesck et al., 1992). It was diluted 1:1,000 in 
PBSI5% BSA. 
For immunohistochemistry, a streptavidin-biotin complex 
protocol was employed. Briefly, tissue sections were deparaf- 
finizcd in xylene and rehydrated through graded ethanol. 
Before incubation with the primary MAbs, sections were 
treated with 0.1% (mg/ml) Protease (bacteroid type xxiv, 
Sigma, St. Louis, MO) at  37°C for 10 min, and then heated in a 
microwave oven at a high power setting (700W) and at  a lower 
power setting (425W) for 5 min, respectively. Endogenous 
peroxidase activity was blocked by using 1% hydrogen perox- 
ide in methanol for 30 min, and the sections were thereafter 
washed in PBS. The sections were incubated for 30 min with 
normal rabbit serum (X902, DAKO) diluted 1 : l O  in PBS/5% 
BSA, then incubated overnight (18-20 hr) with the primary 
antibody at  room temperature (20-22°C). After washing in 
PBS, the sections were incubated with biotinylated, rabbit 
anti-mouse IgG (E354, DAKO) used at a dilution of 1:200 in 
PBS/S% BSA, for 60 min. The sections were washed in PBS, 
then incubated for 30 min with an avidin biotin complex (ABC, 
K355, DAKO). The sections were developed in the peroxidase 
substrate 3-amino-9-ethylcarbazole (AEC, Vector, Burlin- 
game, CA) for 30 min, washed and slightly counterstained with 
hematoxylin (20 scc) dissolved in water and mounted with a 
water-soluble mounting medium (Immu-mount, Shandon, Pitts- 
burgh, PA). Control sections were incubated in duplicate with 
PBS or normal rabbit serum instead of the primary antibody. 
Evaluation of the irnrnunohistochernistry 
Whole-tissue sections (including the epithelium subjaccnt to 
the non-malignant, pre-malignant and malignant areas when 
present in the specimens) were examined with a light micro- 
scope for p53-positive nuclear staining. The staining was 
recorded as positive (+; > 10% of all the tumor cells positive) 
for nuclear p53 staining and as negative (-; < 10% positive 
cells) for negative staining. 
Statistical analysis 
Using Chi-square statistical analyses a t p  < 0.05 significance 
level, the difference in the level of expression of p53 in the 
suspected pre-malignant and malignant oral SCCs from the 
Sudan, Sweden and Norway was investigated. p53 expression 
was also correlatcd with snuff dipping and/or cigarette smok- 
ing. 
p53. 
K ES U LTS 
Light microscopic evaluation 
Histopathological evaluation of the oral tissue specimens is 
shown in Tables I11 and IV. Thcre were no differences in the 
histological pictures of the oral SCCs from snuff-dippers and 
non-snuff-dippers from the Sudan. 
p53 expression 
Descriptions of p53 expression (DO-7, DO-l), snuff dipping 
and sites of the oral lesions are shown in Tables 111 and IV. Of 
the 14 oral SCCs from Sudanese snuff dippers, 21% (3/14) 
p53 EXPRESSION A N D  S N U F F  DIPPING 75 1 
TABLE 111 - PROPORTION OF pS3 EXPRESSION (DO-7. DO-1) IS ORAL SOUAMOUS-CELL CARCINOMAS (SCCs) 
AMONG SNUI:I:-DIPPERS FROM THE SUDAN AND NON-SNUFF-DIPPERS FK0.U THE SUDAN, SWEDEN AND 
NORWAY. DISTRIBUTION ACCORDING TO ANATOMICAI. SITE 
Snuff dippers Non-snuff-dippers 
Lesion 
Sudanese (n = 14) Sudanese (n = 14) Swedish (n = 60) Norwegian (n = 41) 
Oral SCCs (n = 129) 3/14 (21% 9/14 (64%)' 39/60 (65%)2 28/41 68%) 
Lip 2/12 (17%{' 214 (50%) 2/4 (50%) 18/28 16401 
Intraoral 1/2 (50%) 7/10 (70%) 37/56 (66%) 10/13 77% 
Ip = 0.013, Chi-square test for oral SCCs from Sudanese snuff-dippers vs. oral SCCs from 
non-snuff-dippers from the 3 countries c~llectively.-~p = 0.0244; 0.0032,0.0024, Chi-square test for 
oral SCCs from snuff dippers in the Sudan vs. oral SCCs from non-snuff-dippers from the Sudan, 
Sweden and Norway respectively.--'p = 0.035, Chi-square test for lip SCCs from snuff dippers from 
the Sudan w. lip SCCs from non-snuff-dippers from the 3 countries collectively. 
TABLE IV - HISTOLOGICAL EVALUATION AND 5 3  EXPRESSION IN 
Fi BRO-EPiTHELiAL HYPERPLAS~AS AND PRE-GALIGNANT ORAL 
LESIONS AMONG SNUFF-DIPPERS FROM TlIE SUDAN AND SWEDEN, 
AND AMONG NON-SNUFF-DIPPERS FROM THE SUDAN AND NORWAY 
Snuff dippers Non-snutf-dippers 
rn: 8) (n = 15) rn = 3) In = 19) 
- 
Lesion Sudanese Swedish Sudanese Norwegian 
Fibro-epithelial 0 2/15 0 0112 
hvDerolasia 
(A'= i7) 
Epithelial dys- 0/7 0 013 1/2 
plasia 
(n = 12) 
Carcinoma in 0/1 0 0 415 
expressed p53 (Table 111; Fig. la, b). The ages of the 3 patients 
were 65, 70 and 75 years, and all had dipped snuff for 35-50 
years. Of the 14 oral SCCs from Sudanese non-snuff-dippers, 
64% (9/14) expressed p53 (Table 111; Fig. 2a). Of the 60 oral 
SCCs from Swedish non-snuff-dippers, 65% (39/60) expressed 
p53 (Table 111; Fig. 2b), while 5 out of the 8 cigarette smokers 
(63%) also expressed p53. Of the 41 oral SCCs from Norwe- 
gian non-snuff-dippers, 68% (28/41) expressed p53 (Table 111; 
Fig. a), while 7 out of the 11 cigarette smokers (64%) 
expressed p53. p53 expressed (in the atypical surface epithe- 
lium as well as in the infiltrating malignant epithelial tissue) in 
the oral SCCs of Sudanese snuff dippers (Fig. la, b) and in 
those of non-snuff-dippers from the Sudan (Fig. 2a), Sweden 
(Fig. 26) and Norway (Fig. 2) was localized to the nuclei, and 
no cytoplasmic staining was seen. 
Statistical analysis of the difference in expression of p53 in 
the oral SCCs from Sudanese snuff-dippers compared to those 
from non-snuff-dippers from all 3 countries was significant 
(Table 111). The difference in expression of p53 was statisti- 
cally significant in the oral SCCs from Sudanese snuff-dippers 
compared to thosc from non-snuff-dippers from the Sudan, 
Sweden and Norway, respectively (Table. 111). The differencc 
in p53 expression in the oral SCCs from non-snuff-dippers 
from the 3 countries was not statistically significant (Chi 
square = 0 . 1 4 , ~  = 0.931). In addition, there was a statistically 
significant difference between the anatomical site o f  the oral 
lesions and p53 expression in the oral SCCs from snuff dippers 
and those from non-snuff-dippers in the 3 countries (Table 
111). The differencc in p53 expression in the oral SCCs from 
Norwegian and Swedish cigarette smokers was not significant 
(Chi square = 0.19, p = 0.663). The positive control sections 
from carcinoma of the cervix were positive for p53, while none 
of the negative control sections from normal oral mucosal 
lcsions expressed p53. 
All the suspected pre-malignant oral lesions from Sudanese 
snuff-dippers and non-snuff-dippers were negative for p53 
(Table IV). Of the 15 oral fibro-epithelial hyperplasias from 
Swedish snuff-dippers, 13% (2/15) expressed p53 (Table IV), 
and the staining was confined to nuclei of the epithelial 
FIGURE 1 - Immunohistochemical staining of p53 in an oral 
squamous-cell carcinoma from a Sudanese snuff-dipper detected 
by monoclonal antibodies (a) DO-7, (b) DO-1. Scale bar = 50 Fm. 
basal-cell layer. The ages of the 2 patients were 36 and 50 
years, and both had dipped snuff for more than 15 years. Of the 
5 carcinomas in situ and the 2 epithelial dysplasias from 
Norwegian non-snuff-dippers, 80% (4/5) and 50% (1/2) cx- 
pressed p53, rcspcctively, (Table IV) and the staining was 
localized to nuclei of the epithelial basal-cell layer. None of the 
12 fibro-epithelial hyperplasias from Norwegian non-snuff- 
dippers expressed p53. 
DISCUSSION 
In the present study, a significantly lower relative frequcncy 
( p  = 0.013) of p53 expression was found in oral SCCs of 
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FIGURE 2 - Immunohistochemical staining of p53 in an oral 
squamous-cell carcinoma from (a )  Sudanese, (b) Swedish and ( c )  
Norwegian non-snuff-dippers detected by monoclonal antibodies 
DO-7 and/or DO-1. Scale bar = 50 wm. 
Sudanese snuff-dippers compared to those of non-snuff- 
dippers from the Sudan, Sweden and Norway. The 3 oral SCCs 
and the 2 oral tibro-epithelial hyperplasias from Sudanese and 
Swedish snuff-dippers, that expressed p53, showed nuclear 
staining. Eleven of the 14 carcinomas from Sudanese snuff- 
dippcrs did not express p53. The findings of a lower relative 
frequency of p53 expression in oral SCCs of snuff-dippers 
agree with results o f  other studies (Ranasinghe er al., 19936; 
Thomas et al., 1994). In addition, the low relative frequency of 
pS3 expression found i n  the oral fibro-epithelial hyperplasias 
of Swedish snuff-dippers correspond to the previous findings of 
Wedcnberg et al. (1996) who also reported a low relative 
frequency of pS3 expression in the same lesions. Several 
mechanisms have been suggested to explain the findings of 
lower relative frequency or absence of p53 expression. Among 
these mechanisms are the occurrence of allelic deletions of the 
p53 locus (Blount et al., 1991). non-sense mutations (Hollstein 
et al., 1991), certain intronic mutations (Takahashi el al., 1990), 
or pS3 degradation by the human papilloma virus (HPV) E6 
protein (Scheffner et al., 1990). In addition, formation of p53 
complexes with other cytoplasmic proteins has been suggested 
(Harlow et al., 1985; Pinhasi-Kimhi et al., 1986). The lower 
relative frequency of p53 expression found in oral SCCs from 
Sudanese snuff-dippers, in the presence of high levels of 
tobacco-specific nitrosamine (TSNA) found in snuff, supports 
the possible occurrence o f  one of these mechanisms. In 
non-tobacco-related neoplasms, howevcr, over-expression of 
p53 has not been shown to be a marker for mutations 
(Thompson et ab, 1992; Barnes et al., 1992). 
The high relative frequency of p53 expression found in oral 
SCCs from non-snuff-dippers was also similar to that observed 
in other studies (Gusterson et al.. 1991; Schipper et al., 1991). 
In addition, cxpression of pS3 in the oral SCCs of cigarette 
smokers from Sweden and Norway was consistent with that 
reported in other studies (Brennan et al., 1995; Lazarus et al., 
1996). These data suggest that a history of cigarette smoking is 
associated with high incidence of p53 expression, as  reported 
by Lazarus et al. (1996). Nevertheless, no data on history of 
alcohol consumption were available from patients from the 
Sudan (a predominantly Muslim population), Sweden and 
Norway. 
Epidemiological studies from the Sudan (Idris ef al., 1994, 
1995, 1996) have suggested a causal relationship between snuff 
dipping and oral SCCs. Sudanese snuff has been reported to 
contain unusually high levels of TSNA, namely ”-nitrosonor- 
nicotine (NNN) and 4-( methyl-nitrosamin0)- 1 -( 3-pyridyl)-l 
butanone (NNK), exceeding the levels reported in any kind of 
smokeless tobacco including Swedish snuff (Hoffmann and 
Adams, 1981; Bhidc etal.. 1987; Brunnemann et al., 1987; Idris 
et al., 1991). Howcvcr, a study from the USA (Lazarus et al., 
1995), using polymcrase chain reaction and single-stranded 
conformation polymorphism analysis, has reported p53 muta- 
tions in a patient with severe oral epithelial dysplasia who had 
dipped snuff for more than 60 years. The lower relative 
frequency of p53 expression found in oral SCCs from Sudanese 
snuff-dippers questions the role of TSNA in induction of oral 
SCCs through p53 inactivation. 
In conclusion, the present study has shown a lower relative 
frequency of pS3 expression in oral SCCs as well as in oral 
fibro-epithelial hypcrplasias from Sudanese and Swedish snuff- 
dippcrs, respectively. compared to oral lesions from non-snuff- 
dippers. The validity of the immunohistochemical techniques 
for detection of pS3 and/or other genetic lesions should be 
examined carefully to  understand the pathogenesis of snuff- 
induced oral SCCs. Studies of pS3 mutations within the coding 
sequence regions of the p53 protein are therefore needed. In 
addition, the role of other oncogenes and co-carcinogens has 
to be investigated in snuff-related hypcrplastic and pre- 
malignant lesions, as well as in oral SCCs, to reveal the 
possible mechanisms of initiation and progression of snuff- 
induced oral lesions. 
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